Clinical Trials
2 trialsNCT06050252 2026-05-22
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05265208 2025-08-06
SIROCHO
Center Eugene Marquis
Phase 2 Recruiting